InNexus Biotechnology Net Income
| IXSBFDelisted Stock | USD 0.0001 0.00 0.00% |
InNexus Biotechnology technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices.
InNexus Biotechnology's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing InNexus Biotechnology's valuation are provided below:InNexus Biotechnology does not presently have any fundamental trends for analysis. This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. InNexus |
Search Suggestions
| I | Intelsat SA | CompanyDelisted |
| IE | Ivanhoe Electric | Company |
| IMPPP | Imperial Petroleum Preferred | Company |
| IAE | Voya Asia Pacific | Fund |
| IG | Principal Exchange Traded Funds | ETF |
| IRX | CBOE 13 Week | Index |
| ID | SPACE | Cryptocurrency |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
CompetitionBased on the recorded statements, InNexus Biotechnology reported net income of (6.69 Million). This is much lower than that of the Biotechnology sector and significantly lower than that of the Health Care industry. The net income for all United States stocks is notably higher than that of the company.
InNexus Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses InNexus Biotechnology's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of InNexus Biotechnology could also be used in its relative valuation, which is a method of valuing InNexus Biotechnology by comparing valuation metrics of similar companies.InNexus Biotechnology is currently under evaluation in net income category among its peers.
InNexus Fundamentals
| Return On Asset | -0.31 | |||
| Current Valuation | 6.69 M | |||
| Shares Outstanding | 163.2 M | |||
| Price To Sales | 17.10 X | |||
| EBITDA | (1.37 M) | |||
| Net Income | (6.69 M) | |||
| Cash And Equivalents | 31.43 K | |||
| Total Debt | 3.36 M | |||
| Book Value Per Share | (0.04) X | |||
| Cash Flow From Operations | (1.59 M) | |||
| Earnings Per Share | (0.01) X | |||
| Beta | 79.03 | |||
| Market Capitalization | 114.24 K | |||
| Total Asset | 3.44 M | |||
| Retained Earnings | (33.15 M) | |||
| Net Asset | 3.44 M |
About InNexus Biotechnology Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze InNexus Biotechnology's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of InNexus Biotechnology using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of InNexus Biotechnology based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
| FSLY | Fastly Class A | |
| MOB | Mobilicom Limited American | |
| CMG | Chipotle Mexican Grill | |
| CSAN | Cosan SA ADR | |
| RKT | Rocket Companies |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Other Consideration for investing in InNexus Stock
If you are still planning to invest in InNexus Biotechnology check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the InNexus Biotechnology's history and understand the potential risks before investing.
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets |